Efficacy and tolerability of mirabegron, a beta(3)-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European-Australian phase 3 trial - Khullar, V; Amarenco, G; Angulo, J C (Eur Urol, 2013)
et al.